Search results
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
Our companies are all taking a fearless approach to improving the lives of patients through bold ideas and transformative science.
Third Rock Ventures | 43,220 followers on LinkedIn. We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine...
At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families. When we founded the firm in 2007, our imaginations were on fire with the possibility of translating scientific discoveries to breakthrough medicines.
Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco. Founded in 2007, the firm invests in biotechnology startups.
Jun 15, 2022 · Third Rock Ventures today announced the closing of Third Rock Ventures Fund VI, raising $1.1 billion. Fund VI will continue Third Rock’s core strategy.
Jun 15, 2022 · Third Rock Ventures just closed out a massive $1.1 billion fund, bringing its total raised over the last 15 years to an eye-popping $3.8 billion—and the firm has no plans to slow down.
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace.
Apr 16, 2024 · Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Third Rock Ventures. Use the PitchBook Platform to explore the full profile.
Jun 7, 2024 · The Third Rock company’s IPO consists of 8 million shares, with a previous range set for $16 to $18 per share. Now, the biotech has debuted at $17 per share, an offering expected to close...
